Protalix BioTherapeutics (PLX) Prepaid Assets (2014 - 2026)

Protalix BioTherapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 27.74% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 27.74% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, up 125.8% from the prior year.
• Prepaid Assets improved to $1.1 million in Q1 2026 per PLX's latest filing, from $1.1 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $2.6 million in Q2 2022 and bottomed at $500000.0 in Q4 2024.
• The 5-year median for Prepaid Assets is $1.1 million (2025), against an average of $1.3 million.
• Across the five-year window, Prepaid Assets plunged 52.61% in 2024 and surged 125.8% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $774000.0 in 2022, then soared by 36.3% to $1.1 million in 2023, then plunged by 52.61% to $500000.0 in 2024, then jumped by 125.8% to $1.1 million in 2025, then climbed by 1.77% to $1.1 million in 2026.
• Per Business Quant, the three latest PLX Prepaid Assets figures stand at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.5 million (Q3 2025).